PHARMACY

BioPlus now dispensing Gilead’s Epclusa

BY David Salazar
ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy announced this week that it is now dispensing Gilead’s recently approved Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg). 
 
The drug, which combines Gilead’s Sovaldi (sofosbuvir) with an NS5A inhibitor called velpatasvir, is indicated to treat all six strains of hepatitis C. 
 
“One of the exciting things for prescribers and patients about Epclusa is that it’s approved to treat all six genotypes,” BioPlus VP pharmaceutical relations Sharon Ferrer said. “In addition, the low cost (wholesale acquisition cost of $74,760) comes in at nearly 50% lower than previous treatments available for the difficult-to-treat genotype 3 of hepatitis C virus.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FlavoRx founder Kramm dies

BY David Salazar
Kenny Kramm with his daughter, Hadley
 
WASHINGTON — Kenny Kramm, founder of FlavoRx, died in a hospital here on July 12 at 55 years old, according to the Washington Post
 
Kramm initially developed flavored additives for medicines in 1990s as a way to help his daughter, Hadley, take her medications. The Post reported that Hadley suffered from seizures following a brain hemorrhage at 10 days old, requiring four daily doses of phenobarbital, which she wasn’t receptive to because of how it tasted. He then began to offer it in his pharmacy, eventually founding FlavoRx, which by 2007 was offered in half of the pharmacies in the United States, according to the Post. Kramm sold FlavoRx about 10 years ago.
 
He is survived by his wife, Shelley, daughters Sarah Spund and Hadley Kramm, parents Harold and Judy Kramm and sister Harriet Pitler. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

PrescribeWellness appoints chief growth officer

BY David Salazar
IRVINE, Calif. — PrescribeWellness has solidified its executive leadership team, announcing Thursday the addition of Kelly Keegan as the company’s chief growth officer. Keegan is tasked with delivering revenue growth in new and existing healthcare verticals, and he joins the company from Xerox Health, where he was SVP sales and business development for the company’s Care Integration Services business. 
 
“We are excited to have Kelly join the leadership team at PrescribeWellness,” PrescribeWellness CEO Al Babbington said. “He possesses a wealth of experience in building relationships within complex market segments. We will leverage his expertise as we boast about our nationwide network of high-performing community pharmacies to payers, self-insured employers and other healthcare businesses.”
 
Before he was at Xerox, Keegan was VP business development for Anthem Blue Cross Blue Shield, where he also served in executive roles in business development and sales, among other divisions. 
 
“Certainly, I was attracted to the rapid growth and impact that PrescribeWellness has had on the healthcare industry,” Keegan said. “Additionally, I was impressed with the people and the way they’ve connected with so many community pharmacies.”
 
Kelly joins Babbington, COO Susan Lewis, chief technology officer Sean Power, CFO Rob Gerger and chief information security officer Todd Plesco on the company’s executive team. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?